OAR 333-024-0260: Alpha-Fetoprotein Testing and Other Serum and Amniotic Fluid Based Markers for Congenital/Genetic Defects: Purpose
Edition: Current OARD snapshotEffective: 2026-01-07Last verified: 2026-09-07
(1) OAR 333-024-0260 through 333-024-0265 shall apply to the assay of Maternal Serum Alpha-Fetoprotein (MSAFP), Amniotic Fluid Alpha-Fetoprotein (AFAFP), Serum Human Chorionic Gonadotropin, Unconjugated Estriol, Amniotic Fluid Acetylcholinesterase or other related markers for the purposes of congenital/genetic screening. (2) All sections of Clinical Laboratory OAR 333-024-0005 through 333-024-0055 shall apply.
Official history and status
Statutory/Other Authority: ORS 438.040
Statutes/Other Implemented: ORS 438.040
History: PH 6-2026, minor correction filed 01/07/2026, effective 01/07/2026 HD 6-1995, f. & cert. ef. 9-13-95 HD 28-1988, f. & cert. ef. 12-7-88
This rule cites
- OAR 333-024-0260 — resolved
- 333-024-0265 — resolved
- OAR 333-024-0005 — resolved
- 333-024-0055 — resolved
Cited by
Official source: https://secure.sos.state.or.us/oard/